Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.055 USD | +2.75% | +47.43% | -24.91% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.91% | 2.64M | |
+9.22% | 105B | |
-0.39% | 104B | |
+4.75% | 22.94B | |
-10.24% | 22.34B | |
-6.59% | 19.25B | |
-39.98% | 17.08B | |
-8.86% | 16.96B | |
+8.44% | 14.16B | |
+39.17% | 12.63B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Transcript : Cyclacel Pharmaceuticals, Inc., Q4 2022 Earnings Call, Mar 06, 2023